Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission

  • End date
    Dec 20, 2028
  • participants needed
  • sponsor
    The First Affiliated Hospital of Xiamen University
Updated on 3 May 2022
renal function
steroidal anti-inflammatory drugs


The multicenter, randomized controlled trial is to investigate and evaluate the effect of NSAIDs therapy on recurrence in patients with axial spondyloarthritis;


To investigate the recurrence rate in remission patients who withdraw NSAIDs therapy in axial spondyloarthritis;

Condition Axial Spondyloarthritis
Treatment To withdraw NSAIDs therapy, To continue NSAIDs therapy
Clinical Study IdentifierNCT03425812
SponsorThe First Affiliated Hospital of Xiamen University
Last Modified on3 May 2022


Yes No Not Sure

Inclusion Criteria

Capable of giving informed consent and complying with the examination program of the protocol
Participants with axial SpA fulfilling the Assessment of Spondyloarthritis international Society 2009 (ASAS) axial SpA classification criteria
Participants must fulfill the criteria of maintaining remission of aSpA, defined as ASDAS<1.3;
Participants must fulfill the criteria of remission of aSpA defined as ASDAS<1.3,then continuous to evaluate every four weeks for three times and ASDAS<1.3 each time
Laboratory results must fulfill following requirements: Hb≥85g/L;3.5×109/L≤WBC Count ≤10×109/L;Platelet count ≥ Normal lower limit; Liver function (ALT、TBIL) ≤Twofold of normal upper limit; Renal function (SCr) ≤Normal upper limit
The pregnancy test must be negative for women of childbearing age; Efficient contraception must be taken for both male and female participants during the trial period and within three months after the end of the trial

Exclusion Criteria

Participants who previously have experienced allergic reactions to NSAIDs or sulfa-drugs
Participants who are intolerant of NSAIDs
Participants who are in active axSpA episodes
Participants with previous or currant ulcers and/or gastrointestinal conditions or bleeding in three months
Participants who were in acute infection or acute attack of chronic infection during screening period
At the time of screening, participants who were in the acute stage of acute infection or chronic infection, and if the acute infection had improved, they could be re-screened
Participants who suffer from invasive fungal infections (e.g. histoplasma, coccidiosis's, candida, aspergillus, blastomyces, pneumocystis, etc.) within the first 6 months of screening; Or opportunistic bacterial infections (e.g. bacterial, viral or other infections, including Legionella and Listeria)
Participants with other autoimmune diseases which are expected to influence the evaluation of experimental medications, such as inflammatory enteritis, psoriasis, uveitis, etc
Participants with previous or currant congestive heart failure, coronary heart disease, serious arrhythmia
Participants with severe, progressive, uncontrolled vital organ and systematic disorders, and other conditions that are considered inappropriate to participate in this trial
Participants with circumstances that may affect the compliance (e.g. prolonged travel or leave, planned relocation, mental illness, lack of motivation to participate, etc.)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note